NewsAAAAI: GLP-1 Receptor Agonists Linked to Reduction in Asthma Exacerbation RiskHealthDay.comMarch 6, 2026
AAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food AllergyMarch 6, 2026
NewsACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common AllergiesHealthDay.comDecember 18, 2020
